Xiaomei Lyu

Dr. Xiaomei Lyu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2022 in Bioresources and Bioprocessing
Verified
Journal Article
Open access
PDF file
XLXiaomei Lyu
Xiaomei Lyu
YLYan Lyu
Yan Lyu
HYHongwei Yu
Hongwei Yu
WCWeiNing Chen
WeiNing Chen
LYLidan Ye
Lidan Ye
RYRuijin Yang
Ruijin Yang
In current years, natural pigments are facing a fast-growing global market due to the increase of people’s awareness of health and the discovery of novel pharmacological effects of various natural pigments, e.g., carotenoids, flavonoids, and curcuminoids. However, the traditional production approaches are source-dependent and generally subject to the low contents of target pigment compounds. In order to scale-up industrial production, many efforts have been devoted to increasing pigment production from natural producers, via development of both in vitro plant cell/tissue culture systems, as well as optimization of microbial cultivation approaches. Moreover, synthetic biology has opened the door for heterologous biosynthesis of pigments via design and re-construction of novel biological modules as well as biological systems in bio-platforms. In this review, the innovative methods and strategies for optimization and engineering of both native and heterologous producers of natural pigments are comprehensively summarized. Current progress in the production of several representative high-value natural pigments is also presented; and the remaining challenges and future perspectives are discussed. Graphical Abstract

11 August 2022 in ACS Synthetic Biology
Verified
Journal Article
Closed access
YLYingjie Liu
Yingjie Liu
DSDONG SONG
DONG SONG
Haitao HuHaitao Hu
Haitao Hu
RYRuijin Yang
Ruijin Yang
XLXiaomei Lyu
Xiaomei Lyu

1 September 2021 in Journal of Dairy Science
Verified
Journal Article
Open access
XZXuan Zhang
Xuan Zhang
YTYanjun Tong
Yanjun Tong
JWJing Wang
Jing Wang
XLXiaomei Lyu
Xiaomei Lyu
RYRuijin Yang
Ruijin Yang
Bacillus subtilis is a generally recognized as safe probiotic, which is used as a starter for natto fermentation. Natto is a functional food with antithrombus function due to nattokinase. Compared with natto, fermented milk is a more popular fermented food, which is commonly fermented by Lactobacillus bulgaricus and Streptococcus. However, there is no report on B. subtilis-fermented milk. In this study, to produce a functional fermented milk with antithrombus function, a B. subtilis strain (B. subtilis JNFE0126) that produced both nattokinase and milk-clotting enzyme was isolated from traditionally fermented natto and used as the starter for the functional fermented milk. In liquid fermentation culture, the peak values of thrombolytic activity and milk-clotting activity were 3,511 U/mL at 96 h and 874.5 Soxhlet unit/mL at 60 h, respectively. The optimal pH and temperature were pH 7.0 at 40°C for nattokinase and pH 6.5 and 55°C for milk-clotting enzyme, respectively. The thrombolytic activity in the fermented milk reached 215.1 U/mL after 8 h of fermentation. Sensory evaluation showed that the acceptance of the milk fermented by B. subtilis JNFE0126 was similar to the traditional milk fermented by L. bulgaricus and S. thermophilus. More importantly, oral intake of the fermented milk by the thrombosis-model mice prevented the development of thrombosis. Our results suggest that B. subtilis JNFE0126-fermented milk has potential as a novel, functional food in the prevention of thrombosis-related cardiovascular diseases.

24 November 2020 in Food & Function
Verified
Journal Article
Closed access
PDF file
XZXuan Zhang
Xuan Zhang
XLXiaomei Lyu
Xiaomei Lyu
YTYanjun Tong
Yanjun Tong
JWJing Wang
Jing Wang
JYJianfen Ye
Jianfen Ye
RYRuijin Yang
Ruijin Yang
Nattokinase is a thrombolytic enzyme obtained from Japanese traditional food natto for prevention and cure of thrombosis-related cardiovascular diseases. However, the effectiveness of nattokinase through oral intake is limited, due to the loss of thrombolytic activity in the acidic gastric juice. In this study, we develop a functional oral delivery system of nattokinase, in which chitosan microparticles were used as the carrier core to load nattokinase via genipin crosslinking and then covered by a casein-based protective shell via transglutaminase (TG) crosslinking. The results of in vitro and in vivo assays, in the aspects of bioactivity, release dynamics, and therapeutic effects, indicated that the bilayer shell–core structure could protect loaded nattokinase from destruction in the gastric juice and achieve its controlled-release in the intestine. This work demonstrates the availability of bilayer shell–core structure design in oral delivery of nattokinase and shows its high potential for application as an anti-thrombosis functional food additive.

7 December 2022 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
LWLu Wang
Lu Wang
JGJiali Gu
Jiali Gu
Wei ZhaoWei Zhao
Wei Zhao
MWMingming Wang
Mingming Wang
KNKuan Rei Ng
Kuan Rei Ng
RYRuijin Yang
Ruijin Yang

1 June 2022 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
YLYingjie Liu
Yingjie Liu
HLHan Liu
Han Liu
Haitao HuHaitao Hu
Haitao Hu
KNKuan Rei Ng
Kuan Rei Ng
RYRuijin Yang
Ruijin Yang
XLXiaomei Lyu
Xiaomei Lyu